Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1991-02-11
1992-12-01
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Lymphokine
5303917, 5303919, A61K 3944, C07K 1528
Patent
active
051679566
ABSTRACT:
The present invention relates to an immunotoxin. The invention further relates to a method of treating T cell leukemias and lymphomas, graft-versus-host diseases, and autoimmune diseases by administering an immunotoxin.
REFERENCES:
Pastan et al (1991) Science 254:1173-1177.
Hauser (1991) Science 254:1167-1172.
Greenfield et al (1987) Science 238:536-539.
Johnson et al (1988) J. Biol. Chem. 263(3):1295-1300.
Myers et al (1989) J. Immunol. Methods 121:129-142.
Neville, Jr. et al. (1989) J. Biol. Chem. 264(25):14653-61.
Urban et al (1988) Cell 54:577-592.
Neville Jr. David M.
Scharff Joshua E.
Kim Kay
Nucker Christine M.
The United States of America as represented by the Department of
LandOfFree
Immunotoxin with in-vivo T cell suppressant activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunotoxin with in-vivo T cell suppressant activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunotoxin with in-vivo T cell suppressant activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-502710